Take heed to this text
Ronovo Surgical introduced at this time that it closed a brand new spherical of financing, bringing its whole funds raised to greater than $50 million since 2020.
Shanghai-based Ronovo develops broad, cross-specialty robotic-assisted surgical procedure (RAS) expertise. LongRiver Investments led the newest financing spherical. Current traders Lilly Asia Ventures, Vivo Capital, Matrix Companions China and GGV Capital participated. CEC Capital acted because the unique monetary advisor.
Ronovo stated it now exits “stealth mode,” unveiling its inaugural Carina robotic platform. Carina, a modular system constructed on proprietary expertise, permits configurable robotic help for laparoscopic surgical procedures throughout a number of specialties.
Add Ronovo to a bunch of firms, massive and small, which are searching for to tackle Intuitive within the soft-tissue robotic surgical procedure house. (Listed below are 16 surgical robotics firms you could know.)
The corporate stated its oversubscribed financing spherical accelerates the multi-discipline scientific trial for Carina. It additionally expects the funds to strengthen R&D and scientific functions growth, in addition to bolster its expertise base.
Extra about Ronovo Surgical and its Carina system
Ronovo developed Carina in collaboration with famend Chinese language laparoscopic surgeons, in keeping with a information launch. It addresses quite a few ache factors in minimally invasive surgical procedures and supplies surgeons with the pliability to decide on the very best devices and essentially the most ideally suited anatomical entry. As such, surgeons can leverage prior laparoscopic coaching and enhance upon their surgical efficiency, the corporate stated.
The corporate famous that Carina minimizes gear footprint to maximise the utilization of working room house. Surgical groups can select between three-module or four-module configurations, Ronovo stated. Surgeons even have a full suite of devices from which to decide on with Carina.
“We’re extraordinarily grateful to our traders for his or her confidence in Ronovo’s technique to democratize robotic surgical procedure,” stated Dr. John Ma, founder, chair and CEO of Ronovo. “From inception, we’ve got stayed true to our perception that innovation should begin from an authentic pursuit to unravel precise unmet scientific wants.”
Editor’s Observe: This text first appeared on sister web site MassDevice.